Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5189918
Max Phase: Preclinical
Molecular Formula: C19H19FN5Na2O9P
Molecular Weight: 513.38
Associated Items:
ID: ALA5189918
Max Phase: Preclinical
Molecular Formula: C19H19FN5Na2O9P
Molecular Weight: 513.38
Associated Items:
Canonical SMILES: O=c1ccn([C@@H]2O[C@H](COCc3cn(C(c4ccc(F)cc4)P(=O)([O-])[O-])nn3)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+]
Standard InChI: InChI=1S/C19H21FN5O9P.2Na/c20-11-3-1-10(2-4-11)18(35(30,31)32)25-7-12(22-23-25)8-33-9-13-15(27)16(28)17(34-13)24-6-5-14(26)21-19(24)29;;/h1-7,13,15-18,27-28H,8-9H2,(H,21,26,29)(H2,30,31,32);;/q;2*+1/p-2/t13-,15-,16-,17-,18?;;/m1../s1
Standard InChI Key: NWTDPAOFEJHBAD-SADSOMEESA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 513.38 | Molecular Weight (Monoisotopic): 513.1061 | AlogP: -1.17 | #Rotatable Bonds: 8 |
Polar Surface Area: 202.02 | Molecular Species: ACID | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.33 | CX Basic pKa: | CX LogP: -1.29 | CX LogD: -3.53 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.23 | Np Likeness Score: -0.02 |
1. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D.. (2021) Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors., 12 (10.0): [PMID:34778769] [10.1039/D1MD00079A] |
2. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D.. (2021) Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors., 12 (10.0): [PMID:34778769] [10.1039/D1MD00079A] |
Source(1):